Genentech USA Inc - Strategic SWOT Analysis Review

July 2021 | 42 pages | ID: G0ADAA36950EN
GlobalData

Abstracts

Genentech USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Genentech USA Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including oncology, immunology, ophthalmology, metabolism, neurology, and infectious disease, among others. Its pipeline products include Emicizumab (RG6013, ACE910), a bispecific monoclonal antibody used to replace the function of protein in the blood clotting process; and Entrectinib (RXDX-101, RG6268), a CNS-active tyrosine-kinase inhibitor intended for the treatment of non-small cell lung cancer; among others. The company has partnership with BioLineRx, Charles River Laboratories International and Amunix, among others. Genentech is headquartered in South San Francisco, California, the US.

Genentech USA Inc Key Recent Developments

May 26,2021: Pieris and Genentech sign $1.4bn respiratory and ophthalmology deal
Mar 24,2021: Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
Dec 08,2020: UK Biobank unveils studies to measure circulating protein concentrations
Dec 07,2020: Blue Shield of California Foundation partners with Genentech to end childhood trauma
Nov 05,2020: Genentech to present new data across 16 blood disorders at the American Society of Hematology 2020 Annual Meeting

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Genentech USA Inc - Key Facts
Genentech USA Inc - Key Employees
Genentech USA Inc - Key Employee Biographies
Genentech USA Inc - Major Products and Services
Genentech USA Inc - History
Genentech USA Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Genentech USA Inc - Business Description
Genentech USA Inc - SWOT Analysis
SWOT Analysis - Overview
Genentech USA Inc - Strengths
Genentech USA Inc - Weaknesses
Genentech USA Inc - Opportunities
Genentech USA Inc - Threats
Genentech USA Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Genentech USA Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 26, 2021: Pieris and Genentech sign $1.4bn respiratory and ophthalmology deal
Mar 24, 2021: Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
Dec 08, 2020: UK Biobank unveils studies to measure circulating protein concentrations
Dec 07, 2020: Blue Shield of California Foundation partners with Genentech to end childhood trauma
Nov 05, 2020: Genentech to present new data across 16 blood disorders at the American Society of Hematology 2020 Annual Meeting
Oct 27, 2020: Lodo Therapeutics achieves second preclinical milestone in its strategic collaboration with Genentech
Oct 06, 2020: Imbio Partners with Genentech to Develop Imaging Diagnostics for Lung Diseases
Oct 02, 2020: Vaccibody, Genentech partner to develop cancer vaccines
Oct 01, 2020: Vaccibody announces update on expanded R&D focus and strategy
Sep 22, 2020: Scenic Biotech forms drug development alliance with Genentech

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Genentech USA Inc, Key Facts
Genentech USA Inc, Key Employees
Genentech USA Inc, Key Employee Biographies
Genentech USA Inc, Major Products and Services
Genentech USA Inc, History
Genentech USA Inc, Other Locations
Genentech USA Inc, Key Competitors
Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Genentech USA Inc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Genentech USA Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Genentech USA Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021